Immuneering Stock Forecast for 2023 - 2025 - 2030
Updated on 05/12/2024
Immuneering Stock Forecast and Price Target
The average price target for Immuneering's stock lately set by several renowned analysts is $16.00, which would result in a potential upside of approximately 1003.45% if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of $25.00 and a low estimate of $4.00.
1003.45% Upside
Immuneering Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Immuneering's Price has increased by 100.00%, going from $0.00 to $0.00. In the next year, analysts are expecting an increase in Fair Value, predicting it will reach $0.00 – an increase of 100.00%. The Immuneering forecast is for Fair Value to reach $0.00 or grow by 100.00%.
Immuneering Revenue Forecast for 2023 - 2025 - 2030
In the last year, Immuneering's Revenue has decreased from $2.08M to $320.00k – a 84.62% drop! In the next year, analysts are expecting an increase in Revenue, predicting it will reach $2.08M – an increase of 550.00%. The Immuneering forecast is for Revenue to reach $7.20M or grow by 2150.99%.
.jpg)
Immuneering EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Immuneering's EBITDA has grown, increasing from $-33.84M to $-58.06M – a growth of 71.57%. According to 0 prominent analysts, Immuneering's EBITDA will fall by 18.98% in the next year, reaching $-47.04M. By 2030, professionals believe that Immuneering's EBITDA will decrease by 18.79%, reaching $-47.15M – a concerning trend for the company.
Immuneering EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Immuneering's EBIT has grown by 72.35%, from $-33.89M to $-58.41M. In the following year, 0 experts forecast Immuneering's EBIT will decrease by 19.11%, to $-47.25M. In 2030, professionals predict that Immuneering's EBIT will decrease by 18.90%, to $-47.37M.
Immuneering EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Immuneering's EPS has increased by 100.00%, going from $-2.46 to $0.00. In the next year, analysts are expecting an increase in EPS, predicting it will reach $0.00 – an increase of 100.00%. The Immuneering forecast is for EPS to reach $0.00 or grow by 100.00%.
.jpg)